Agfa Healthcare has expanded its RIS portfolio with the purchase of a minority stake in Med2Rad, an Italian medical software company. Med2Rad developed the Elefante RIS, currently installed in more than 75 Italian hospitals. The Belgian company has for
Agfa Healthcare has expanded its RIS portfolio with the purchase of a minority stake in Med2Rad, an Italian medical software company. Med2Rad developed the Elefante RIS, currently installed in more than 75 Italian hospitals. The Belgian company has for several years been the exclusive marketer and vendor for Elefante in the Italian market, as part of an integrated RIS/PACS and as a stand-alone RIS. Agfa made the investment to allow greater integration between its Impax and Med2Rad's Elefante, leading eventually to a common IT platform, according to the firm.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.